Benzinga's Top Upgrades

Analysts at Morgan Stanley upgraded Valeant Pharmaceuticals International VRX from “equal-weight” to “overweight.” The target price for Valeant Pharmaceuticals is set to $145. Valeant's shares closed at $125.35 yesterday. Deutsche Bank upgraded Hershey Company (The) HSY from “hold” to “buy.” The target price for Hershey has been raised from $90 to $108. Hershey's shares closed at $97.00 yesterday. Analysts at Citigroup upgraded The NASDAQ OMX Group NDAQ from “neutral” to “buy.” The target price for NASDAQ OMX Group has been raised from $40 to $50. NASDAQ OMX Group's shares closed at $40.07 yesterday. JP Morgan upgraded Rite Aid RAD from “neutral” to “overweight.” The target price for Rite Aid has been raised from $6 to $6.50. Rite Aid's shares closed at $5.31 yesterday.